Blackstone to acquire life sciences firm Clarus
Blackstone has agreed to acquire Clarus, a global life sciences investment firm that has raised USD2.6 billion since its founding. Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage investments, often in partnership with major biopharmaceutical companies through R&D collaborations. These investments